Evolent Health
EVH
251 hedge funds and large institutions have $4.12B invested in Evolent Health in 2024 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 90 increasing their positions, 81 reducing their positions, and 23 closing their positions.
98% more call options, than puts
Call options by funds: $15.5M | Put options by funds: $7.82M
83% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 23
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
11% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 81
7% more funds holding
Funds holding: 234 → 251 (+17)
2% less capital invested
Capital invested by funds: $4.2B → $4.12B (-$71.7M)
1.48% less ownership
Funds ownership: 110.51% → 109.03% (-1.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$102M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$17.5M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$17.2M |
| 4 |
Millennium Management
New York
|
+$16.5M |
| 5 |
Holocene Advisors
New York
|
+$12.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$73.3M |
| 2 |
JP Morgan Chase
New York
|
-$37.4M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$36M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$28.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$23.3M |
EVH Hedge Fund Activity: Q1 2024 in Review
251 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q1 2024, worth a combined $4.12B — down 1.7% from $4.2B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new EVH positions and 23 closed out — a net gain of 19 holders — while 90 added to existing stakes and 81 trimmed.
The largest buyer was RA Capital Management, adding an estimated $102M. The largest seller was Fidelity Investments, cutting an estimated $73.3M.
- 251 institutional investors held Evolent Health (EVH) as of Q1 2024, up from 234 in Q4 2023.
- Funds reported $4.12B of Evolent Health stock for Q1 2024, down 1.7% quarter-over-quarter.
- 42 funds opened new Evolent Health positions in Q1 2024 and 23 closed out, a net change of +19 holders.
- The largest Evolent Health buyer in Q1 2024 was RA Capital Management, an estimated $102M added.
- The largest Evolent Health seller in Q1 2024 was Fidelity Investments, an estimated $73.3M sold.
Based on aggregated 13F filings for Q1 2024.